A Deep Dive into new residency programs

10 min read
New Growth in Graduate Medical Education

New residency programs are the fastest-growing segment of graduate medical education, and most applicants evaluate them with a gut feeling and a glossy website. That is a statistical error, and it is an avoidable one.

The scale is larger than most applicants realize. The ACGME now accredits more than 13,000 residency and fellowship programs, and it grants initial accreditation to several hundred new programs every academic year. The single accreditation system merger absorbed hundreds of former AOA programs after 2015. Large health systems, HCA Healthcare is the obvious example, have built dozens of new programs from scratch across Texas, Florida, and the Southeast. The pipeline is not slowing down. My review of public ACGME accreditation reports shows the trend holding steady at roughly 300 new initial accreditations per year, with heavy concentration in internal medicine, family medicine, emergency medicine, and psychiatry.

This matters to your career for one simple reason: new programs are simultaneously the highest-risk and highest-value targets on the Match landscape. The risk is real, no board pass rate history, no fellowship placement record, no alumni network. The value is also real, less entrenched competition, more faculty attention per resident, and, for DOs and IMGs especially, materially higher interview yield. I have watched applicants with average scores match into excellent training environments at new programs while their higher-scoring classmates fought over brand-name interviews. The difference was not luck. It was analysis.

Treat the chart above as directional, not gospel. Pull the current ACGME accreditation report yourself before you build a list, the numbers shift, and the merger-era spike in 2020 and 2021 distorts any simple average. The pattern, however, is unambiguous: every Match cycle now contains hundreds of programs with zero graduates and zero outcome data. You will either evaluate those programs rigorously or you will guess. Guessing is how people end up miserable.

The Core Challenge

The central problem with new programs is missing data. Established programs come with a longitudinal record: five-year board pass rates, fellowship match lists, graduate job placement, citation histories. New programs come with a PDF of ambitions. You are, in a very literal sense, being asked to become the first data point.

Here are the pitfalls I see applicants hit most often, and what the numbers actually say about each one.

Pitfall 1: Confusing "new" with "weak." The data does not support blanket avoidance. Programs launched under experienced sponsoring institutions, hospitals that already run 10, 20, or 40 other accredited programs, inherit governance structures, GME offices, and institutional memory from day one. A new program under a mature sponsor behaves very differently from a standalone startup program. Treating them as one category is sloppy analysis.

Pitfall 2: Ignoring accreditation status granularity. "Accredited" is not a binary variable in practice. There is Initial Accreditation, Continued Accreditation, and, the one that matters, the citation record. A program with Initial Accreditation and a clean sponsoring institution is a reasonable bet. A program whose sponsor carries citations across multiple other programs is a structural risk, regardless of how nice the interview day felt.

Pitfall 3: Underestimating fill-rate signal. First-year fill rates for new community programs frequently land between 60 and 85 percent, with heavy reliance on the SOAP. That is not automatically disqualifying, many strong programs filled through the SOAP in year one and filled outright by year three. What matters is the trajectory. A program trending 60, then 85, then 100 percent across three cycles is healing. A program stuck at 50 percent for three consecutive years is telling you something. Listen to it.

Pitfall 4: Dismissing closure risk. It is rare, a single-digit percentage, but it is not zero. When a program closes, residents become orphans, and while the ACGME requires transfer support, the practical experience is disruptive and stressful. The strongest predictors of closure are sponsor instability and hospital financial distress. A new program attached to a rural hospital with shaky finances carries a fundamentally different risk profile than a new program attached to a growing regional system. Check the hospital's financials. Almost nobody does this. You should.

Pitfall 5: Believing the brochure over the spreadsheet. Every new program's website promises "individualized attention" and "a chance to shape the curriculum." Sometimes that is genuinely true. I worked with an inaugural-class resident at a new Florida internal medicine program who spent her PGY-2 year helping write the didactic curriculum herself, she described it as building the plane while flying it. She also matched a cardiology fellowship. Both things were true: the chaos and the opportunity. Your job is to quantify which force dominates at a given program.

Who feels the risk most acutely? Not everyone equally. The match rate gap by applicant type is one of the most consistent findings in NRMP data:

Read that chart carefully. If you are a U.S. MD senior with a 93-plus percent baseline match probability, new programs are a value play, optional, opportunistic, worth including selectively. If you are a non-U.S.-citizen IMG staring down a sub-60 percent baseline, new programs are not optional at all. They are frequently your highest-probability targets, because the data shows new programs fill disproportionately with DOs and IMGs. The same program is a different strategic object depending on who is holding it. That is the entire point of evidence-based list building.

Weighing Evidence Over Marketing

Actionable Next Steps

Enough diagnosis. Here is the protocol I would follow if I were building a rank list tomorrow.

  1. Build the dataset first. Filter your specialty in FREIDA for programs with no graduating classes yet. Cross-reference each one against the ACGME public accreditation search to confirm Initial Accreditation and record the exact accreditation date. A program accredited 60 days before the Match is a different entity from one accredited three years ago.

  2. Score every program on a weighted rubric. My recommended weights: sponsoring institution track record (25 percent), program director experience (20 percent), case volume and facility quality (20 percent), location and visa sponsorship fit (15 percent), fill-rate trajectory (10 percent), rotation and elective structure (10 percent). Adjust the weights to your situation, an IMG should push visa fit higher, but never skip the scoring step. Unweighted impressions are how marketing departments win.

  3. Verify claims with numbers on interview day. Do not ask "Is the curriculum strong?" Ask: How many full-time equivalent faculty are hired and on contract? What is the simulation budget? How many continuity clinic sessions per week? What board review resources are funded? A program director who cannot answer with numbers is a data point in itself, a negative one. I once sat across from a PD at a brand-new community program who could quote his projected case logs down to the procedure but could not tell me how many faculty he had actually hired. That gap is where risk lives.

  4. Track the fill trajectory across two or three cycles. NRMP publishes Results and Data for every Main Match. Look up the program's fill numbers each year. Rising trajectory, flat trajectory, declining trajectory, rank them accordingly.

  5. Construct a mixed rank list. If you are a competitive applicant, treat strong new programs as mid-tier value picks, not list anchors. If you are a DO or IMG, invert that: new programs under credible sponsors should occupy the bulk of your list, because that is where your probability mass actually sits.

Your primary resources: FREIDA, the ACGME ADS public search, NRMP Results and Data and Charting Outcomes, the AAMC Residency Explorer tool, and your specialty's match reports. Resident forums can supplement this, but weight them low, anecdote is not a dataset.

For quick decisions, run every program through this filter:

The flowchart is deliberately conservative. Programs that clear all four gates, accreditation confirmed, mature sponsor, experienced program director, rising fill trajectory, deserve a rank position comparable to mid-tier established programs, because the inputs that predict resident outcomes are present even though the outcomes have not published yet. Programs that fail two or more gates belong at the bottom of your list or off it entirely. Sharp lines beat soft feelings here.

Key Takeaways

  • Be prepared: build the spreadsheet before interview season, verify every claim against primary sources, and score programs on weighted criteria rather than vibes.
  • Focus on high-yield areas: sponsor track record, PD experience, and fill trajectory explain most of the variance in new-program quality, spend your research hours there, not on website aesthetics.
  • Match strategy is applicant-type dependent; new programs are a value play for competitive applicants and a probability play for DOs and IMGs.
  • Trajectory beats snapshot in every case. A rising fill rate forgives a rough first year.
01 How do I start evaluating new residency programs before application season?

Begin by planning your schedule early and using verified resources. Concretely: set aside two to three weeks in the spring, pull the FREIDA list of programs with no graduates, confirm each program's status in the ACGME public database, and enter everything into a spreadsheet with the weighted criteria above. Applicants who start in August compress this work into panicked weekends, and the data shows rushed analysis produces list-building errors, usually overweighting location and underweighting sponsor quality.

02 Are new residency programs actually a better bet for IMGs and DOs?

Yes, and this is one of the most defensible claims in this article. NRMP data shows baseline match rates near 67 percent for U.S.-citizen IMGs and under 60 percent for non-U.S.-citizen IMGs, and new programs fill disproportionately from exactly these applicant pools. A new program under a strong sponsor offers higher interview probability and genuine training quality. The caveat: verify visa sponsorship explicitly, because new community programs vary widely and assumptions here are costly.

03 What single data point best predicts whether a new program will survive and train residents well?

The sponsoring institution's accreditation history. It is not a perfect predictor, no single variable is, but a sponsor running multiple accredited programs with a clean citation record provides governance, GME infrastructure, and institutional commitment that a first-time sponsor simply cannot replicate on day one. Program director experience runs a close second. If you only have time to check two things before ranking a new program, check those two, and check them in the primary sources, not on the program's own website.


Keep reading

View more